Plasma circulating cell–free DNA integrity and relative telomere length as diagnostic biomarkers for Parkinson’s disease and multiple system atrophy: a cross-sectional study

Plasma circulating cell–free DNA integrity and relative telomere length as diagnostic biomarkers for Parkinson’s disease and multiple system atrophy: a cross-sectional study

In clinical specialties focusing on neurological disorders, there is a need for comprehensive and integrated non-invasive, sensitive, and specific testing methods. Both Parkinson’s disease and multiple system atrophy are classified as α-synucleinopathies, characterized by abnormal accumulation of α-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chao Ying, Chao Han, Yuan Li, Mingkai Zhang, Shuying Xiao, Lifang Zhao, Hui Zhang, Qian Yu, Jing An, Wei Mao, Yanning Cai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-12-01
Series:	Neural Regeneration Research
Subjects:	biomarkers cell-free dna diagnosis multiple system atrophy neurodegenerative diseases parkinson’s disease risk factors
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00599
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern Imaging Methods in the Diagnosis of Neurodegenerative Diseases
by: Paulina Dorota Pietrukaniec, et al.
Published: (2025-02-01)

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
by: Mingchun Jiang, et al.
Published: (2025-02-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
by: Fangda Leng, et al.
Published: (2025-01-01)

Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
by: Anna-Sophia Hartke, et al.
Published: (2025-02-01)

VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
by: Shirel Argueti-Ostrovsky, et al.
Published: (2024-12-01)

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosisResearch in context
by: Dang Wei, et al.
Published: (2025-03-01)

GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
by: Wang Y, et al.
Published: (2025-02-01)

Assisted Parkinsonism Diagnosis Using Multimodal MRI—The Role of Clinical Insights
by: Tobias Meindl, et al.
Published: (2025-01-01)

Outcomes of dietary interventions in the prevention and progression of Parkinson's disease: A literature review
by: Ubaid Ansari, et al.
Published: (2024-12-01)

Neuroprotective Effects of Myrtle Berry By-Product Extracts on 6-OHDA-Induced Cytotoxicity in PC12 Cells
by: Debora Dessì, et al.
Published: (2025-01-01)

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases
by: Andrea Stoccoro
Published: (2025-01-01)

Progress of deep brain stimulation for Parkinson's disease
by: BAI Yu⁃tong, et al.
Published: (2025-01-01)

The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
by: Bedri Ranxhi, et al.
Published: (2025-02-01)

Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases
by: Ana Romero Garavito, et al.
Published: (2025-01-01)

Multi-functional role of apolipoprotein E in neurodegenerative diseases
by: Sadequl Islam, et al.
Published: (2025-01-01)

Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting
by: Andrea Merlo, et al.
Published: (2025-01-01)

Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
by: Virendra Kumar Yadav, et al.
Published: (2025-01-01)

Glycolytic pathways: The hidden regulators in Parkinson's disease
by: Jing Shen, et al.
Published: (2025-02-01)

Psychosis in Parkinson's disease in a Southeast Asian cohort: prevalence and clinical correlates
by: Vanessa Wai Ling Mok, et al.
Published: (2022-12-01)

Evaluation of compliance and accuracy in Parkinson’s disease motor symptom tracking: a comparative study of digital and traditional paper diaries using a smartphone application (MyParkinson’s)
by: Nazli Durmaz Celik, et al.
Published: (2025-01-01)

The Multifactorial Memory Questionnaire and Quality of Life: A Longitudinal Study in Parkinson’s Disease
by: Emily J. Corti, et al.
Published: (2025-01-01)

Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson’s disease
by: Yong Hui Nies, et al.
Published: (2025-01-01)

Genetic screening of South African families with Parkinson’s disease
by: S Bardien, et al.
Published: (2024-02-01)

Effects of exercise training on the nigrostriatal glutamatergic pathway and receptor interactions in Parkinson’s disease: a systematic review
by: Shahid Ishaq, et al.
Published: (2025-02-01)

Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease and vascular parkinsonism
by: A. A. Makarova, et al.
Published: (2025-01-01)

LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease
by: Lu Han, et al.
Published: (2025-03-01)

Uncovering the molecular mechanisms behind Alzheimer’s and Parkinson’s disease through multi-omics: an interview with Bruno A. Benitez
by: Bruno A. Benitez
Published: (2025-01-01)

The Role of AMPS in Parkinson’s Disease Management: Scoping Review and Meta-Analysis
by: Roberto Tedeschi, et al.
Published: (2024-12-01)

From small to tall: breed-varied household pet dogs can be trained to detect Parkinson’s Disease
by: Lisa Holt, et al.
Published: (2024-10-01)

Transcriptome analysis of muscle atrophy in Leizhou black goats: identification of key genes and insights into limb-girdle muscular dystrophy
by: Ke Wang, et al.
Published: (2025-01-01)

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
by: Yi Zhang, et al.
Published: (2025-12-01)

FundusNet: A Deep-Learning Approach for Fast Diagnosis of Neurodegenerative and Eye Diseases Using Fundus Images
by: Wenxing Hu, et al.
Published: (2025-01-01)

Gamma knife thalamotomy for essential and Parkinson’s tremor
by: A. Radžiūnas, et al.
Published: (2021-03-01)

Mendelian randomization analysis of the causal relationship between trimethylamine N-oxide and its precursors and Parkinson’s disease
by: Bei Zhang, et al.
Published: (2024-12-01)

The Role of Virtual Reality in Postural Rehabilitation for Patients with Parkinson’s Disease: A Scoping Review
by: Francesco Agostini, et al.
Published: (2024-12-01)

Causal relationship between lipid profile and muscle atrophy: A bi‐directional Mendelian randomization study
by: Kun Chen, et al.
Published: (2025-01-01)

Digital dance programs for Parkinson's disease: challenges and opportunities
by: Judith Bek, et al.
Published: (2025-01-01)

Parkinson’s disease and exosomes: from pathogenesis to diagnosis and treatment
by: A. Mišeikaitė, et al.
Published: (2021-06-01)

The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
by: Jevgenija Guk, et al.
Published: (2024-03-01)